How much Novo Nordisk’s weight-loss drug Wegovy costs can depend on a lot of things, which makes it very hard for the average ...
This follows recent successful efforts by the Trump administration to cut the price of this compound for certain patients.
1d
Explainer: Novo Nordisk’s two-brand bet, how Ozempic and Wegovy are carving India’s GLP-1 market
While both drugs share the same active ingredient, their positioning, pricing, and regulatory pathways diverge sharply, ...
The survey showed that while most of the doctors didn’t have top-of-mind awareness of oral semaglutide’s upcoming FDA ...
Novo Nordisk said on Friday the European Medicines Agency's committee had issued a positive opinion for a higher dose of its ...
5hon MSN
Popular weight-loss drugs like Wegovy fail to lower obesity-related cancer risks, study finds
Researchers analysed 48 previously-conducted trials which examined the safety and efficacy of GLP-1 drugs on people with type ...
Novo Nordisk announced today that Health Canada has issued marketing authorization with conditions [Notice of Compliance with ...
Obesity is a big driver of healthcare spending in South Africa, yet most medical schemes still limit cover for effective ...
1hOpinion
We must stay vigilant on false patent extensions and the non-clinical use of weight-loss drugs
The Indian judiciary did well not to let Novo Nordisk extend its exclusive right to sell semaglutide, marketed as Ozempic and ...
EMA issues positive opinion on Novo Nordisk's higher-dose Wegovy, supported by strong weight-loss data and ongoing reviews in ...
Can Novo Nordisk get its comeback going in 2026? Let's discuss two things that could materialize for the company next year ...
Target has expanded its protein and supplement sections as GLP-1 drugs like Ozempic reshape shopping habits, driving demand ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback